We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIT icon
801
CALL
Alight
ALIT
$375M
$1K ﹤0.01%
50
– –
ASTS icon
802
CALL
AST SpaceMobile
ASTS
$21.8B
$1K ﹤0.01%
15
-103
-87% -$7.35K
OPTU
803
Optimum Communications Inc
OPTU
$229M
$1K ﹤0.01%
+1,200
New +$2.44K
BCYC
804
CALL
Bicycle Therapeutics
BCYC
$280M
$1K ﹤0.01%
157
+17
+12% +$125
BF.A icon
805
Brown-Forman Class A
BF.A
$13.1B
$1K ﹤0.01%
60
– –
BITO icon
806
CALL
ProShares Bitcoin Strategy ETF
BITO
$1.44B
$1K ﹤0.01%
+141
New +$2.21K
BITO icon
807
ProShares Bitcoin Strategy ETF
BITO
$1.44B
$1K ﹤0.01%
130
-353
-73% -$5.54K
BTG icon
808
CALL
B2Gold
BTG
$6.79B
$1K ﹤0.01%
+400
New +$1.86K
CARV
809
DELISTED
Carver Bancorp
CARV
$1K ﹤0.01%
1,600
– –
CCJ icon
810
CALL
Cameco
CCJ
$42.8B
$1K ﹤0.01%
+11
New +$991
CENTA icon
811
Central Garden & Pet Co Class A
CENTA
$2.44B
$1K ﹤0.01%
60
-80
-57% -$2.31K
CLX icon
812
CALL
Clorox
CLX
$12.7B
$1K ﹤0.01%
+15
New +$1.63K
CRSP icon
813
CALL
CRISPR Therapeutics
CRSP
$5.2B
$1K ﹤0.01%
+20
New +$1.2K
CRTO icon
814
CALL
Criteo S.A. Ordinary Shares
CRTO
$869M
$1K ﹤0.01%
+60
New +$1.24K
GRAB icon
815
CALL
Grab
GRAB
$14.7B
$1K ﹤0.01%
+250
New +$1.38K
HII icon
816
Huntington Ingalls Industries
HII
$12.8B
$1K ﹤0.01%
+5
New +$1.55K
IMNM icon
817
Immunome
IMNM
$3.08B
$1K ﹤0.01%
+50
New +$878
LAES icon
818
CALL
SEALSQ Corp
LAES
$622M
$1K ﹤0.01%
+506
New +$2.58K
LBTYK icon
819
Liberty Global Class C
LBTYK
$3.42B
$1K ﹤0.01%
100
+30
+43% +$334
MA icon
820
Mastercard
MA
$489B
$1K ﹤0.01%
+3
New +$1.68K
MBI icon
821
MBIA
MBI
$255M
$1K ﹤0.01%
150
– –
NNN icon
822
NNN REIT
NNN
$8.87B
$1K ﹤0.01%
+35
New +$1.44K
ONDS icon
823
CALL
Ondas Inc
ONDS
$5.22B
$1K ﹤0.01%
+105
New +$843
OSCR icon
824
Oscar Health
OSCR
$9.23B
$1K ﹤0.01%
100
-241
-71% -$4.17K
PCM
825
PCM Fund
PCM
$70.1M
$1K ﹤0.01%
300
– –
31 32
33
34 35

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.